SEMINAR: Challenges in Patients with Peripheral Vascular Disease

Amit Dwlvedi, MD, PhD
When Feb 21, 2018
from 12:00 PM to 01:30 PM
Where Shumaker Research Bldg, RM 139
Contact Name
Contact Phone 852-7485
Add event to calendarvCal
iCal

Abstract:  The talk will present the current clinical challenges with peripheral vascular diseases encourtered during his clinical practice. The talk will also cover current approaches, their drawbacks, and current clinical needs where bioengineers can provide innovative solutions.r risks; however, not many of us asks what are the effects of radiation at low and very low doses. In fact, low-dose radiation (LDR) modulates a variety of immune responses, such as stimulating effects that may reduce cancer risk, which are called adaptive or hormetic response. Although the underlying molecular mechanism is not fully understood yet, increasing evidence implies that LDR has potential to be used clinically for the treatment of autoimmune diseases, malignant tumors and even other chronic diseases. This presentation will introduce the historic discovery and increasing recognition of the unexpected effect and its potential application in the clinics.

Speaker:Dr. Amit Dwivedi is Associate professor of surgery and Chief of the Division of vascular surgery at University of Louisville. After graduating from his medical school from Grant medical college in Mumbai, India, he moved to the US where he did his general surgery at Wayne state university. He finished his fellowship in vascular surgery at North Shore and long Island Jewish medical center in New York. He has been a faculty member at the University of Louisville since 2006. He has a busy clinical practice and has published over 50 peer reviewed manuscripts. He has participated in multiple industry sponsored trials over these years. Dr. Dwivedi’s clinical interests include diseases of the thoracic aorta (TEVAR), hemodialysis access, continuous study of the roles of open, hybrid, minimally invasive endovascular therapies, and prevention and treatment of neointimal hyperplasia, which is the bane of vascular surgery outcomes.

View Seminar on YouTube